Norway· NO-ID_FF2865A0-9725-490B-99E3-B35BC1C04A29
Mysimba
A bupropion and naltrexone product containing bupropion hydrochloride + naltrexone hydrochloride, registered in Norway by 2care4 ApS. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Bupropion and naltrexone is registered in 12 of 19 countries.
Countries holding a registration under ATC A08AA62 (bupropion and naltrexone), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Bupropion and naltrexone · ATC A08AA62
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Bupropion Hydrochloride + Naltrexone Hydrochloride
- Manufacturer
- 2care4 ApS
- Country
- Norway (NO)
- ATC code
- A08AA62
- ATC class
- Bupropion and naltrexone
- Defined daily dose
- 4 DE, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_FF2865A0-9725-490B-99E3-B35BC1C04A29
- no_varenummer130348112NOK 1249.9
- gtin5712923020793
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bupropion and naltrexone in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMysimbaOrifarm Oy
- CzechiaMYSIMBAOrexigen Therapeutics Ireland Limited, Dublin
- United KingdomMysimba 8mg/90mg prolonged-release tabletsOrexigen Therapeutics Ireland Ltd
- IrelandMysimba 8 mg/90 mg prolonged-release tabletsOrexigen Therapeutics Ireland Limited
- IcelandMysimbaOrexigen Therapeutics Ireland Limited
- NetherlandsMysimba 8 mg/90 mg tabletten met verlengde afgifteOrexigen Therapeutics Ireland Limited
- PolandMysimbaOrexigen Therapeutics Ireland Limited
- SwedenMysimba 8 mg/90 mg DepottablettOrexigen Therapeutics Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Mysimba
- Liechtenstein · Mysimba
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0cf6150c-a7d6-4cee-9d80-a54d107ba387 GET /v1/drugs/0cf6150c-a7d6-4cee-9d80-a54d107ba387?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Depottablett",
"source": "fest",
"status": "A",
"atc_name": "Bupropion og naltrekson",
"merkevare_id": "ID_FF2865A0-9725-490B-99E3-B35BC1C04A29",
"name_form_strength": "Mysimba depottab 8 mg/90 mg",
"prescription_group": "C"
}See everything about bupropion and naltrexone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.